Literature DB >> 5639105

Disposition of thalidomide in rabbits and rats.

H Schumacher, D A Blake, J R Gillette.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5639105

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

1.  Differential effects of thalidomide on angiogenesis and tumor growth in mice.

Authors:  A V Belo; M A Ferreira; A A Bosco; R D Machado; S P Andrade
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients.

Authors:  S C Piscitelli; W D Figg; B Hahn; G Kelly; S Thomas; R E Walker
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 3.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.

Authors:  G B Gordon; S P Spielberg; D A Blake; V Balasubramanian
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits.

Authors:  H M Verheul; D Panigrahy; J Yuan; R J D'Amato
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 6.  Clinical pharmacokinetics of thalidomide.

Authors:  Steve K Teo; Wayne A Colburn; William G Tracewell; Karin A Kook; David I Stirling; Markian S Jaworsky; Michael A Scheffler; Steve D Thomas; Oscar L Laskin
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 5.577

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.